Memorandum by Royal Brompton and Harefield
NHS Trust (AL 14)
We face a major epidemic of allergy within
the UK at present. There has been a twofourfold increase
in allergy related disorders including asthma, rhinitis and anaphylaxis.
Allergy services within UK are grossly inadequate in the face
of this serious public health problem which affects around 30%
of the UK population. For example, there are only six full time
specialist allergy clinics throughout the whole of England and
no such service in Wales, Scotland or Northern Ireland.
My clinic at Royal Brompton Hospital is one
of three such clinics in London and, like elsewhere, specialist
allergy services are focussed in academic centres when much of
the provision for NHS services is obtained piecemeal and dependent
inappropriately, on university funding. My post is only funded
2/11ths by the NHS, together with one full time Specialist Registrar
in Allergy and the support of a dietician with an interest in
food allergy. Nonetheless, the service is supported largely by
my clinical research fellows and specialist research nurse who
provide a major service role for NHS patients. This situation
is clearly unsatisfactory and not feasible outside an academic
setting.
A major problem is that the typical allergic
patient has diseases affecting the multiple organ systems including
eyes, nose, chest, skin, gastro-intestinal tract with or without
the risk of potential life-threatening anaphylaxis. A good example
is the peanut sensitive child (currently 2% of children in the
UK are peanut allergic). These patients are at risk of life threatening
anaphylaxis, particularly in those who have associated bronchial
asthma. A second example is the patient who has a life-threatening
adverse reaction under general anaesthesia. Such cases require
obsessional evaluation and investigation in a day care specialist
allergy setting. A third example is the 5-10% of adult asthma
patients who have an occupational cause for their asthma which
requires detailed evaluation.
These cases emphasise the need for a multi-disciplinary
approach which can only be provided by a specialist allergy centre.
The current piecemeal service provided at secondary care level
by individual organ specialists is inadequate. For example, a
chest physician may be competent to evaluate the allergic component
of asthma. He may or may not recognise that the patient has associated
distressing allergic rhinitis requiring separate management. Almost
certainly, he would not be equipped to investigate and diagnose
associated food allergy. Neither could he deal with associated
urticaria or difficult eczema. Such a patient requires one consultant
allergist with a multi-disciplinary approach to diagnosis and
treatment rather than the alternative, namely, four to five organ
specialists to deal with multiple allergic problems.
The priorities should be as follows:
1. Establishment of regional centres throughout
the UK, including Wales, Scotland and Northern Ireland. Such a
regional centre should comprise two Consultant Allergists, a minimum
of one Paediatric Allergist, a full time allergy nurse, two specialist
trainees in allergy and a half time dietician with a specialist
interest in food allergy.
Such a service should provide:
(a) a supra regional service for tertiary referrals
from organ-based specialists; and
(b) a local service for primary referrals of
patients with multiple allergies.
2. Such a regional centre would be committed
to training Specialist Registrars in Allergy for the future. Equally
important, the regional service could provide training in allergy
for organ-based specialists at secondary care level. A third important
aspect of training involves education at primary care level of
General Practitioners and Practice Nurses.
3. Finally, regional centres should ensure
that allergy is a proper part of the under-graduate medical student
curriculum in order to ensure that future doctors in all specialities
and within general practice are aware of the current epidemic
in allergy within the UK and the need for appropriate reform.
In Cambridge Dr Pamela Ewan has provided a role
model for how an NHS-Funded regional allergy centre can provide
a supra-regional and regional service and training at tertiary,
secondary and primary care level. As a first step such NHS-funded
centres could be set up throughout the 11 regions within the UK.
May 2004
|